Studies on the Role of Amino Acid Stereospecificity in Amyloid Beta Aggregation
暂无分享,去创建一个
[1] M. Gallagher,et al. A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.
[2] J. Mothet,et al. Gliotransmission at central glutamatergic synapses: d-serine on stage , 2006, Journal of Physiology-Paris.
[3] Michela Gallagher,et al. A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.
[4] O. Guillard,et al. Mechanism of Alzheimer's disease: Arguments for a neurotransmitter-aluminium complex implication , 1990, Neurochemical Research.
[5] Isao Kaneko,et al. β‐Amyloid Racemized at the Ser26 Residue in the Brains of Patients with Alzheimer Disease: Implications in the Pathogenesis of Alzheimer Disease , 2003, Journal of neuropathology and experimental neurology.
[6] T. Kubo,et al. In vivo conversion of racemized β‐amyloid ([D‐Ser26]Aβ1–40) to truncated and toxic fragments ([D‐Ser26]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients , 2002 .
[7] T. Kubo,et al. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. , 2002, Journal of neuroscience research.
[8] T. Shirasawa,et al. Isoaspartate formation and neurodegeneration in Alzheimer's disease. , 2000, Archives of biochemistry and biophysics.
[9] P. Lansbury,et al. Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.
[10] C. Glabe,et al. Soluble Amyloid Aβ-(1–40) Exists as a Stable Dimer at Low Concentrations* , 1997, The Journal of Biological Chemistry.
[11] C. Cotman,et al. All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids* , 1997, The Journal of Biological Chemistry.
[12] T. Shirasawa,et al. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease. , 1994, The Tohoku journal of experimental medicine.
[13] T. Shirasawa,et al. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. , 1994, The Journal of biological chemistry.
[14] H. Levine,et al. Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.
[15] M J Ball,et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.
[16] C. Glabe,et al. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] C. Cotman,et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.
[18] C. Barrow,et al. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.
[19] K. Wilkinson,et al. Racemization of Individual Aspartate Residues in Human Myelin Basic Protein , 1988, Journal of neurochemistry.
[20] O. Ptitsyn,et al. Sequential mechanism of refolding of carbonic anhydrase B , 1987, FEBS letters.
[21] S. Clarke,et al. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. , 1987, The Journal of biological chemistry.
[22] T. Thomas,et al. Quasielastic laser light scattering and electron microscopy studies of the conformational transitions and condensation of poly(dA‐dT) · poly(dA‐dT) , 1985, Biopolymers.